Skip to Content

1,979 Results Found

  • Review
  • Open Access
1 Citations
372 Views
8 Pages

Consensus Statement on the Management of Patients with HCV Infection in Romania

  • Consensus Statement on HCV Infection in Romania Working Group

1 March 2017

Background: HCV direct-acting antivirals (DAAs) have made treatment easier for both patients and healthcare practitioners, but have also brought new challenges in terms of patient management and monitoring prior to, during, and after treatment. Metho...

  • Article
  • Open Access
2 Citations
2,045 Views
11 Pages

Prevalence of Hepatitis C in the Emilia-Romagna Region of Italy: Population-Wide Screening

  • Gianmarco Imperiali,
  • Matteo Fiore,
  • Alessandro Bianconi,
  • Giovanna Mattei and ,
  • Giulio Matteo,
  • Giuseppe Diegoli,
  • Esther Rita De Gioia,
  • Cecilia Acuti Martellucci,
  • Maria Elena Flacco and
  • Regional HCV Working Group
  • + 6 authors+ 1 author

12 June 2025

In agreement with WHO recommendations, the Emilia-Romagna Region, Italy, implemented a population-wide HCV screening program for the treatment of the large asymptomatic infected population. From January 2022, the free-of-charge screening targeted all...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Article
  • Open Access
2 Citations
2,956 Views
12 Pages

Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b

  • Mohammad Alkhatib,
  • Velia Chiara Di Maio,
  • Valentina De Murtas,
  • Ennio Polilli and ,
  • Martina Milana,
  • Elisabetta Teti,
  • Gianluca Fiorentino,
  • Vincenza Calvaruso,
  • Silvia Barbaliscia and
  • on behalf of HIRMA (Hepatocarcinoma Innovative Research MArkers) and Fondazione Vironet C (HCV Virology Italian Resistance
  • + 25 authors+ 20 authors

23 April 2021

HCV is an important cause of hepatocellular carcinoma (HCC). HCV NS5A domain-1 interacts with cellular proteins inducing pro-oncogenic pathways. Thus, we explore genetic variations in NS5A domain-1 and their association with HCC, by analyzing 188 NS5...

(This article belongs to the Special Issue Viral Resistance in HCV Infection)
  • Article
  • Open Access
291 Views
13 Pages

Clinical Performance of the Elecsys HCV Duo Immunoassay Compared with a Standard-of-Care Algorithm Using Alinity Anti-HCV Screening and HCV RNA Confirmation

  • Jaeeun Yoo,
  • Hye-Sun Park,
  • JoungOk Kim,
  • Sang-Ik Cho and ,
  • Seong Hwan Jo,
  • Seo-A Park,
  • Min-Seok Kwon,
  • Ae-Ran Choi and
  • Eun-Jee Oh
  • + 4 authors+ 0 author

7 October 2026

Background/Objectives: The Elecsys HCV Duo immunoassay simultaneously detects HCV core antigen (HCV Ag) and anti-HCV antibodies in a single sample. We evaluated its clinical performance against a standard-of-care reference algorithm of anti-HCV antib...

(This article belongs to the Section Clinical Laboratory Medicine)
  • Article
  • Open Access
4 Citations
3,004 Views
15 Pages

Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study

  • Daniel Sepúlveda-Crespo,
  • Camilla Volpi,
  • Rafael Amigot-Sánchez,
  • María Belén Yélamos and ,
  • Cristina Díez,
  • Julián Gómez,
  • Víctor Hontañón,
  • Juan Berenguer,
  • Juan González-García and
  • Isidoro Martínez
  • + 7 authors+ 2 authors

30 August 2024

Background: This study evaluated titers and amplitudes of anti-E2 antibodies (anti-E2-Abs) and neutralizing antibodies against hepatitis C virus (HCV; anti-HCV-nAbs) in HIV/HCV-coinfected individuals over five years after successful HCV treatment com...

(This article belongs to the Section Biopharmaceuticals)
  • Article
  • Open Access
44 Citations
6,822 Views
12 Pages

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors

  • Tiziana Latronico,
  • Claudia Mascia,
  • Ilaria Pati,
  • Paola Zuccala and ,
  • Fabio Mengoni,
  • Raffaella Marocco,
  • Tiziana Tieghi,
  • Valeria Belvisi,
  • Miriam Lichtner and
  • Grazia Maria Liuzzi
  • + 7 authors+ 2 authors

An imbalance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) may contribute to liver fibrosis in patients with hepatitis C (HCV) infection. We measured the circulating levels of different MMPs and TIMPs in...

(This article belongs to the Special Issue Infectious Diseases: Pathophysiology, Diagnostics, Therapies, and Prevention)
  • Brief Report
  • Open Access
10 Citations
3,832 Views
8 Pages

Performance of Elecsys® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection

  • Prooksa Ananchuensook,
  • Jongkonnee Wongpiyabovorn,
  • Anchalee Avihingsanon and
  • Pisit Tangkijvanich

29 September 2024

Background/Objectives: The Elecsys® HCV Duo immunoassay (Roche Diagnostics International Ltd., Rotkreuz, Switzerland) detects both antibodies to hepatitis C virus (anti-HCV) and HCV core antigen (HCV-Ag) and has shown excellent diagnostic perform...

(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)
  • Article
  • Open Access
3,343 Views
9 Pages

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients

  • Daniel Fuster,
  • David Nunes,
  • Debbie M. Cheng,
  • Richard Saitz and
  • Jeffrey H. Samet

21 April 2021

Background: The impact of Hepatitis C virus (HCV) RNA levels on the evolution of chronic HCV infection-related liver damage is controversial. Heavy alcohol use is believed to have a deleterious impact on the course of HCV disease, but current knowled...

(This article belongs to the Special Issue HIV and Drugs of Abuse)
  • Review
  • Open Access
2 Citations
3,700 Views
16 Pages

21 May 2023

The hepatitis C virus (HCV) is potentially associated with liver cancer, and advances in various drugs have led to progress in the treatment of hepatitis C and attempts to prevent its transition to liver cancer. Furthermore, reactivation of HCV has b...

  • Article
  • Open Access
6 Citations
2,015 Views
14 Pages

HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination

  • Christos Thomadakis,
  • Dimitrios Basoulis,
  • Olga Tsachouridou,
  • Konstantinos Protopapas and ,
  • Vasilios Paparizos,
  • Myrto Astriti,
  • Maria Chini,
  • Georgios Chrysos,
  • Markos Marangos and
  • Giota Touloumi
  • + 12 authors+ 7 authors

30 May 2024

People living with HIV-HCV co-infection comprise a target group for HCV-micro-elimination. We conducted an HCV cascade of care (CoC) for HIV-HCV co-infected individuals living in Greece and investigated factors associated with different HCV-CoC stage...

(This article belongs to the Special Issue Cascade of Care for HIV and Hepatitis)
  • Review
  • Open Access
44 Citations
6,846 Views
26 Pages

Long non-coding RNAs (lncRNAs) are transcripts with poor coding capacity that may interact with proteins, DNA, or other RNAs to perform structural and regulatory functions. The lncRNA transcriptome changes significantly in most diseases, including ca...

(This article belongs to the Special Issue Hepatitis C Virus – Molecular Biology, Disease and Treatment (Section 1))
  • Article
  • Open Access
7 Citations
3,239 Views
19 Pages

Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile

  • Emiliano Dalla,
  • Michela Bulfoni,
  • Daniela Cesselli,
  • Riccardo Pravisani and ,
  • Masaaki Hidaka,
  • Susumu Eguchi and
  • Umberto Baccarani
  • + 2 authors+ 0 author

16 February 2022

Background: After liver transplantation, HCV/HIV co-infected patients present, compared to the HCV mono-infected ones, increased HCV viral load, rapid progression to liver fibrosis and higher mortality. Liver biopsies (LB), obtained routinely 6 month...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms Governing Liver Pathophysiology)
  • Article
  • Open Access
12 Citations
4,791 Views
22 Pages

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection

  • Óscar Brochado-Kith,
  • Alicia Gómez Sanz,
  • Luis Miguel Real,
  • Javier Crespo García and ,
  • Pablo Ryan Murúa,
  • Juan Macías,
  • Joaquín Cabezas González,
  • Jesús Troya,
  • Juan Antonio Pineda and
  • Amanda Fernández-Rodríguez
  • + 12 authors+ 7 authors

Factors involved in the spontaneous cleareance of a hepatitis C (HCV) infection are related to both HCV and the interaction with the host immune system, but little is known about the consequences after a spontaneous resolution. The main HCV extrahepa...

(This article belongs to the Special Issue Immunobiology Pathogenesis and Therapeutic Perspectives in Viral Hepatitis)
  • Article
  • Open Access
3 Citations
284 Views
7 Pages

The Prevalence of HCV RNA Positivity in Anti-HCV Antibodies-Negative Hemodialysis Patients in Thrace Region. Multicentral Study

  • Eleni I. Konstantinidou,
  • Eftychia G. Kontekaki,
  • Aristidis Kefas,
  • Theocharis Konstantinidis and ,
  • Gioulia Romanidou,
  • Eleni Fotiadou,
  • Viki Rekari,
  • Eleni Triantafyllidou,
  • Stavroula Zisaki and
  • Konstantinos Mimidis
  • + 13 authors+ 8 authors

15 March 2021

Introduction: HCV infection in patients under hemodialysis for end stage chronic kidney disease (ESCKD) may exist despite the absence of anti-HCV antibodies. Molecular methods are widely accepted as “gold standard” techniques for the detection of vir...

  • Article
  • Open Access
9 Citations
3,489 Views
15 Pages

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study

  • Martina Spaziante,
  • Gloria Taliani,
  • Giulia Marchetti,
  • Alessandro Tavelli and ,
  • Miriam Lichtner,
  • Antonella Cingolani,
  • Stefania Cicalini,
  • Elisa Biliotti,
  • Enrico Girardi and
  • Alessandro Cozzi-Lepri
  • + 8 authors+ 3 authors

19 July 2021

Objectives: HCV shows complex interactions with lipid metabolism. Our aim was to examine total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) changes in HIV/HCV coinfected patients, after achieving sustained virological response (SV...

(This article belongs to the Special Issue HIV-1 Infection and Immunometabolism: Relevance to HIV Pathogenesis and Persistence)
  • Article
  • Open Access
11 Citations
5,318 Views
25 Pages

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV

  • María Q. Marín,
  • Kwinten Sliepen,
  • Juan García-Arriaza,
  • Sylvie M. Koekkoek and ,
  • Patricia Pérez,
  • Carlos Óscar S. Sorzano,
  • Carmen E. Gómez,
  • Rogier W. Sanders and
  • Mariano Esteban
  • + 4 authors+ 0 author

5 August 2020

Hepatitis C virus (HCV) represents a major global health challenge and an efficient vaccine is urgently needed. Many HCV vaccination strategies employ recombinant versions of the viral E2 glycoprotein. However, recombinant E2 readily forms disulfide-...

(This article belongs to the Section Hepatitis Virus Vaccines)
  • Review
  • Open Access
16 Citations
6,275 Views
13 Pages

Hepatitis C virus (HCV) is an RNA virus that can efficiently establish chronic infection in humans. The overlap between the HCV replication cycle and lipid metabolism is considered to be one of the primary means by which HCV efficiently develops chro...

(This article belongs to the Special Issue Apolipoprotein E and Pathogenic Mechanisms in Human Diseases and Disorders)
  • Article
  • Open Access
8 Citations
3,178 Views
20 Pages

Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects

  • Paola Zuccalà,
  • Tiziana Latronico,
  • Raffaella Marocco,
  • Stefano Savinelli and ,
  • Serena Vita,
  • Fabio Mengoni,
  • Tiziana Tieghi,
  • Cosmo Borgo,
  • Blerta Kertusha and
  • Miriam Lichtner
  • + 10 authors+ 5 authors

8 October 2022

In the direct-acting antiviral (DAA) era, it is important to understand the immunological changes after HCV eradication in HCV monoinfected (mHCV) and in HIV/HCV coinfected (HIV/HCV) patients. In this study, we analyzed sub-populations of monocytes,...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
2 Citations
2,831 Views
16 Pages

HIV, HCV and HIV-HCV Coinfections in the General Population versus Inmates from Romania

  • Camelia Sultana,
  • Carmine Falanga,
  • Grațiana Chicin,
  • Laurențiu Ion and ,
  • Camelia Grancea,
  • Daniela Chiriac,
  • Adriana Iliescu and
  • Andrea Gori
  • + 3 authors+ 0 author

10 August 2024

The objective of this study was to analyze the epidemiological links of the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and HIV-HCV coinfections to less studied types of transmission in certain populations. We performed an observation...

(This article belongs to the Special Issue HIV and HTLV Infections and Coinfections)
  • Brief Report
  • Open Access
2 Citations
1,523 Views
15 Pages

Persistent Low Anti-HIV Neutralizing Antibody Titers in HIV/HCV Coinfection Despite HCV Cure: A 5-Year Longitudinal Analysis

  • Daniel Sepúlveda-Crespo,
  • Víctor Sánchez-Merino,
  • Rafael Amigot-Sánchez,
  • Almudena Rubio-Pérez and ,
  • Cristina Díez,
  • Víctor Hontañón,
  • Juan Berenguer,
  • Juan González-García,
  • Felipe García and
  • Salvador Resino
  • + 7 authors+ 2 authors

Background: Anti-HIV neutralizing antibodies (anti-HIV-nAbs) play a critical role in the immune defense against HIV by preventing viral entry and limiting replication. This study longitudinally evaluated the titers and variability of anti-HIV-nAbs in...

(This article belongs to the Special Issue Vaccines and Vaccination: HIV, Hepatitis Viruses, and HPV)
  • Review
  • Open Access
37 Citations
14,609 Views
20 Pages

Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies

  • Shrikant Dashrath Warkad,
  • Keum-Soo Song,
  • Dilipkumar Pal and
  • Satish Balasaheb Nimse

30 September 2019

Hepatitis C virus (HCV) accounts for 15%–20% of cases of acute infection, and chronic HCV infection is developed in about 50%–80% of HCV patients. Unfortunately, due to the lack of proper medical care, difficulty in screening for HCV infe...

(This article belongs to the Section Biosensors)
  • Article
  • Open Access
7 Citations
4,197 Views
14 Pages

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients

  • Beatriz Álvarez,
  • Clara Restrepo,
  • Marcial García,
  • María A. Navarrete-Muñoz and ,
  • María A. Jiménez-Sousa,
  • Laura Prieto,
  • Alfonso Cabello,
  • Sara Nistal,
  • Salvador Resino and
  • José M. Benito
  • + 7 authors+ 2 authors

Systemic inflammation, endothelial dysfunction and coagulopathy are of high clinical relevance in the management of people living with HIV (PLWH), and even more in patients coinfected with hepatitis C virus (HCV). It has been suggested a significant...

(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)
  • Review
  • Open Access
5 Citations
13,828 Views
16 Pages

30 November 2009

Hepatitis C virus (HCV) establishes a persistent infection in more than 70% of infected individuals. This striking ability to evade the powerful innate immune system results from viral interference occurring at several levels of the interferon (IFN)...

(This article belongs to the Special Issue Hepatitis Viruses)
  • Review
  • Open Access
38 Citations
20,585 Views
23 Pages

Lipid Metabolism and HCV Infection

  • Paul Targett-Adams,
  • Steeve Boulant,
  • Mark W. Douglas and
  • John McLauchlan

11 May 2010

Chronic infection by hepatitis C virus (HCV) can lead to severe liver disease and is a global healthcare problem. The liver is highly metabolically active and one of its key functions is to control the balance of lipid throughout the body. A number o...

(This article belongs to the Special Issue Role of Lipids in Virus Replication)
  • Article
  • Open Access
27 Citations
3,765 Views
14 Pages

Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience

  • Andrea Marino,
  • Gabriella Zafarana,
  • Manuela Ceccarelli,
  • Federica Cosentino and ,
  • Vittoria Moscatt,
  • Gabriele Bruno,
  • Roberto Bruno,
  • Francesco Benanti,
  • Bruno Cacopardo and
  • Benedetto Maurizio Celesia
  • + 5 authors+ 0 author

11 December 2021

HCV treatment became available for all infected patients regardless of their comorbidities, especially for HIV coinfected subjects, leading to an improvement in both clinical and immunological conditions. We retrospectively analyzed a cohort of HIV/H...

(This article belongs to the Special Issue Diagnosis and Management of HIV Infection)
  • Article
  • Open Access
49 Citations
4,701 Views
17 Pages

HCV-Associated Exosomes Upregulate RUNXOR and RUNX1 Expressions to Promote MDSC Expansion and Suppressive Functions through STAT3–miR124 Axis

  • Bal Krishna Chand Thakuri,
  • Jinyu Zhang,
  • Juan Zhao,
  • Lam N. Nguyen and ,
  • Lam N. T. Nguyen,
  • Madison Schank,
  • Sushant Khanal,
  • Xindi Dang,
  • Dechao Cao and
  • Zhi Q. Yao
  • + 12 authors+ 7 authors

18 December 2020

RUNX1 overlapping RNA (RUNXOR) is a long non-coding RNA and plays a pivotal role in the differentiation of myeloid cells via targeting runt-related transcription factor 1 (RUNX1). We and others have previously reported that myeloid-derived suppressor...

  • Article
  • Open Access
13 Citations
3,290 Views
19 Pages

Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy

  • Stefania Farcomeni,
  • Sonia Moretti,
  • Caterina Fimiani,
  • Lucia Fontanelli Sulekova and ,
  • Fenicia Vescio,
  • Leonardo Sernicola,
  • Maria T. Maggiorella,
  • Anna Lisa Remoli,
  • Orietta Picconi and
  • Alessandra Borsetti
  • + 11 authors+ 6 authors

15 November 2021

Background: Direct-acting antivirals (DAAs) treatment, although highly efficacious for the treatment of hepatitis C virus (HCV) infection, may not completely reconstitute the HCV-mediated dysregulated immune system, especially in patients co-infected...

(This article belongs to the Special Issue Advances in HCV Research)
  • Review
  • Open Access
1,188 Views
17 Pages

Assembly of a Functional HCV Glycoprotein Heterodimer

  • Muriel Lavie,
  • Anne Goffard and
  • Jean Dubuisson

The two HCV envelope glycoproteins E1 and E2 are released from HCV polyprotein by signal peptidase cleavages. These glycoproteins are type I transmembrane proteins with a highly glycosylated N-terminal ectodomain and a C-terminal hydrophobic anchor....

  • Review
  • Open Access
37 Citations
10,508 Views
26 Pages

HCV Detection, Discrimination, and Genotyping Technologies

  • Shrikant Dashrath Warkad,
  • Satish Balasaheb Nimse,
  • Keum-Soo Song and
  • Taisun Kim

12 October 2018

According to the World Health Organization (WHO), 71 million people were living with Hepatitis C virus (HCV) infection worldwide in 2015. Each year, about 399,000 HCV-infected people succumb to cirrhosis, hepatocellular carcinoma, and liver failure....

(This article belongs to the Special Issue Biosensors for the Detection of Biomarkers)
  • Review
  • Open Access
20 Citations
5,572 Views
23 Pages

From Structural Studies to HCV Vaccine Design

  • Itai Yechezkel,
  • Mansun Law and
  • Netanel Tzarum

4 May 2021

Hepatitis C virus (HCV) is a serious and growing public health problem despite recent developments of antiviral therapeutics. To achieve global elimination of HCV, an effective cross-genotype vaccine is needed. The failure of previous vaccination tri...

(This article belongs to the Special Issue Novel Advances in Vaccines against HCV)
  • Article
  • Open Access
39 Citations
8,789 Views
27 Pages

Humanized-VHH Transbodies that Inhibit HCV Protease and Replication

  • Surasak Jittavisutthikul,
  • Jeeraphong Thanongsaksrikul,
  • Kanyarat Thueng-in,
  • Monrat Chulanetra and ,
  • Potjanee Srimanote,
  • Watee Seesuay,
  • Aijaz Ahmad Malik and
  • Wanpen Chaicumpa
  • + 3 authors+ 0 author

20 April 2015

There is a need for safe and broadly effective anti-HCV agents that can cope with genetic multiplicity and mutations of the virus. In this study, humanized-camel VHHs to genotype 3a HCV serine protease were produced and were linked molecularly to a c...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
6 Citations
3,251 Views
17 Pages

Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients

  • Kamil Grubczak,
  • Anna Grzeszczuk,
  • Monika Groth,
  • Anna Hryniewicz and ,
  • Anna Kretowska-Grunwald,
  • Robert Flisiak and
  • Marcin Moniuszko
  • + 2 authors+ 0 author

25 July 2021

Approximately 25% of HIV-infected patients are co-infected with HCV. Notably, the burden of HCV infection (e.g., viral persistence, viral load, or HCV-related liver symptoms) is more pronounced in the presence of HIV co-infection. However, to date, t...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Review
  • Open Access
14 Citations
3,535 Views
8 Pages

11 April 2022

Hepatitis C virus (HCV) is highly prevalent in Russia, representing the largest pool of hepatitis C patients in Europe. Effective treatment regimens with direct-acting antivirals can achieve HCV cure in all patients; therefore, in 2016 the World Heal...

(This article belongs to the Special Issue Ways to Eliminate Viral Hepatitis as a Global Health Threat)
  • Review
  • Open Access
26 Citations
4,350 Views
11 Pages

Autophagy in HCV Replication and Protein Trafficking

  • Ja Yeon Kim Chu and
  • Jing-hsiung James Ou

22 January 2021

Autophagy is a catabolic process that is important for maintaining cellular homeostasis. It is also known to possess other functions including protein trafficking and anti-microbial activities. Hepatitis C virus (HCV) is known to co-opt cellular auto...

(This article belongs to the Section Molecular Immunology)
  • Review
  • Open Access
39 Citations
7,187 Views
12 Pages

Replication of the hepatitis C virus (HCV) strongly relies on various lipid metabolic processes in different steps of the viral life cycle. In general, HCV changes the cells’ lipidomic profile by differentially regulating key pathways of lipid...

(This article belongs to the Special Issue Hepatitis C Virus – Molecular Biology, Disease and Treatment (Section 1))
  • Review
  • Open Access
16 Citations
12,322 Views
14 Pages

5 August 2010

A critical role of Cyclophilins, mostly Cyclophilin A (CyPA), in the replication of HCV is supported by a growing body of in vitro and in vivo evidence. CyPA probably interacts directly with nonstructural protein 5A to exert its effect, through its p...

(This article belongs to the Special Issue Antivirals Against Hepatitis C Virus)
  • Article
  • Open Access
4 Citations
4,021 Views
15 Pages

Time and Mode of Epidemic HCV-2 Subtypes Spreading in Europe: Phylodynamics in Italy and Albania

  • Erika Ebranati,
  • Alessandro Mancon,
  • Martina Airoldi,
  • Silvia Renica and ,
  • Renata Shkjezi,
  • Pranvera Dragusha,
  • Carla Della Ventura,
  • Anna Rita Ciccaglione,
  • Massimo Ciccozzi and
  • Gianguglielmo Zehender
  • + 10 authors+ 5 authors

17 February 2021

Hepatitis C virus (HCV) genotype 2 causes about 10% of global infections and has the most variable circulation profile in Europe. The history of “endemic” HCV-2 subtypes has been satisfactorily reconstructed, instead there is little information about...

(This article belongs to the Special Issue Molecular Detection and Typing of Viruses)
  • Article
  • Open Access
4 Citations
4,632 Views
11 Pages

Selective Depletion of ZAP-Binding CpG Motifs in HCV Evolution

  • Sanket Mukherjee,
  • Akhil Kumar,
  • Jasmine Samal,
  • Ekta Gupta and ,
  • Perumal Vivekanandan and
  • Manoj B. Menon
  • + 1 author+ 0 author

27 December 2022

Hepatitis C virus (HCV) is a bloodborne pathogen that can cause chronic liver disease and hepatocellular carcinoma. The loss of CpGs from virus genomes allows escape from restriction by the host zinc-finger antiviral protein (ZAP). The evolution of H...

(This article belongs to the Special Issue Advances in HCV Research)
  • Review
  • Open Access
28 Citations
4,912 Views
15 Pages

2 February 2021

Hepatitis C virus (HCV) is a major cause of death and morbidity globally and is a leading cause of hepatocellular carcinoma (HCC). Incidence of HCV infections, as well as HCV-related liver diseases, are increasing. Although now, with new direct actin...

(This article belongs to the Special Issue Viral Hepatitis and Risk of Hepatocellular Carcinoma)
  • Article
  • Open Access
1 Citations
2,145 Views
12 Pages

Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype

  • Giulia Morsica,
  • Riccardo Vercesi,
  • Hamid Hasson,
  • Emanuela Messina and ,
  • Caterina Uberti-Foppa and
  • Sabrina Bagaglio
  • + 1 author+ 0 author

29 July 2021

Resistance-associated substitutions (RASs) may exist prior to treatment and contribute to the failure of treatment with direct-acting antivirals (DAAs). As the major site of HCV replication, naturally occurring variants with RASs may segregate into t...

(This article belongs to the Special Issue Viral Resistance in HCV Infection)
  • Article
  • Open Access
13 Citations
4,624 Views
17 Pages

NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients

  • Maria Concetta Bellocchi,
  • Marianna Aragri,
  • Luca Carioti,
  • Lavinia Fabeni and ,
  • Rosaria Maria Pipitone,
  • Giuseppina Brancaccio,
  • Maria Chiara Sorbo,
  • Silvia Barbaliscia,
  • Velia Chiara Di Maio and
  • Francesca Ceccherini-Silberstein
  • + 15 authors+ 10 authors

2 July 2019

Background: The aim of the study was to investigate the intra-host variability through next-generation-sequencing (NGS) of the NS5A-gene in nosocomial transmission-clusters observed in two Italian hospitals among hepatitis C virus (HCV)-genotype-1b i...

(This article belongs to the Special Issue Hepatitis C Virus and Host Interactions)
  • Article
  • Open Access
18 Citations
3,775 Views
13 Pages

Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy

  • Daniele Lapa,
  • Paola Del Porto,
  • Claudia Minosse,
  • Gianpiero D’Offizi and ,
  • Andrea Antinori,
  • Maria Rosaria Capobianchi,
  • Ubaldo Visco-Comandini,
  • Fiona McPhee,
  • Anna Rosa Garbuglia and
  • Mauro Zaccarelli
  • + 5 authors+ 0 author

13 May 2021

Torque Teno virus (TTV) is a ubiquitous virus that causes chronic infection in humans with unknown clinical consequences. Here, we investigated the influence of TTV infection on HCV direct-acting antiviral (DAA) efficacy in HIV/HCV coinfected and HCV...

(This article belongs to the Section Infectious Diseases)
  • Article
  • Open Access
2 Citations
2,971 Views
10 Pages

Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects

  • Valeria Bono,
  • Camilla Tincati,
  • Lorena Van Den Bogaart,
  • Elvira Stefania Cannizzo and ,
  • Roberta Rovito,
  • Matteo Augello,
  • Anna De Bona,
  • Antonella D’Arminio Monforte,
  • Laura Milazzo and
  • Giulia Marchetti
  • + 5 authors+ 0 author

22 July 2022

HIV-HCV co-infected subjects are at risk of liver fibrosis which may be linked to immune imbalances. Direct-acting antivirals (DAAs) represent the mainstay of HCV treatment in co-infected individuals, yet their effects on immune cell populations play...

(This article belongs to the Special Issue HIV-1 and Hepatitis Virus Co-infection)
  • Viewpoint
  • Open Access
7 Citations
2,573 Views
11 Pages

The elimination of HCV (hepatitis C virus) infection is, according to WHO (World Health Organization), of international interest. With new diagnostic tools and treatment possibilities, one major challenge for the elimination is to involve infected pa...

  • Review
  • Open Access
11 Citations
4,604 Views
16 Pages

Immunopotentiating and Delivery Systems for HCV Vaccines

  • Alexander K. Andrianov and
  • Thomas R. Fuerst

25 May 2021

Development of preventive vaccines against hepatitis C virus (HCV) remains one of the main strategies in achieving global elimination of the disease. The effort is focused on the quest for vaccines capable of inducing protective cross-neutralizing hu...

(This article belongs to the Special Issue Novel Advances in Vaccines against HCV)
  • Article
  • Open Access
1 Citations
2,501 Views
14 Pages

Are We on the Right Track for HCV Micro-Elimination? HCV Management Practices in Dialysis Centers in Poland—A National Cross-Sectional Survey

  • Paulina Czarnecka,
  • Kinga Czarnecka,
  • Olga Tronina,
  • Teresa Baczkowska and ,
  • Weronika Zarychta-Wisniewska and
  • Magdalena Durlik
  • + 1 author+ 0 author

4 April 2023

Chronic hepatitis C (CHC) is prevalent in the hemodialysis-dependent population. Currently, all patients with CHC should be considered for treatment; however, many hemodialysis-dependent patients are still left untreated. Following HCV cure, accurate...

(This article belongs to the Special Issue Chronic HCV Infection: Clinical Advances and Eradication Perspectives - Part II)
  • Brief Report
  • Open Access
2 Citations
824 Views
8 Pages

HCV Screening in a Sicilian Centre: A Descriptive Cohort Profile

  • Maria G. Minissale,
  • Salvatore Petta and
  • Fabio Cartabellotta

16 September 2025

Introduction: Hepatitis C virus (HCV) infection prevalence in Italy varies according to geographical areas and clusters of infection. Moreover, epidemiological studies are old, and the actual prevalence of HCV active infections is also affected by th...

(This article belongs to the Special Issue Advancing Hepatitis Elimination: HBV, HDV, and HCV)
  • Review
  • Open Access
40 Citations
6,988 Views
21 Pages

Oncogenic Signaling Induced by HCV Infection

  • Alessia Virzì,
  • Armando Andres Roca Suarez,
  • Thomas F. Baumert and
  • Joachim Lupberger

2 October 2018

The liver is frequently exposed to toxins, metabolites, and oxidative stress, which can challenge organ function and genomic stability. Liver regeneration is therefore a highly regulated process involving several sequential signaling events. It is th...

(This article belongs to the Special Issue Cure of Hepatitis C Virus Infection and Hepatocellular Carcinoma)
  • Article
  • Open Access
4 Citations
3,554 Views
9 Pages

HCV Co-Infection and Its Genotypic Distribution in HIV-Infected Patients in Nepalese Population

  • Uday Kant Sah,
  • Anil Kumar Sah,
  • Mehraj Ansari,
  • Priyanka Chaudhary and ,
  • Saurav Gupta,
  • Pawan Kumar and
  • Jay Prakash Sah
  • + 2 authors+ 0 author

Hepatitis C Virus (HCV) co-infection and its genotypic distribution in people living with Human Immunodeficiency Virus (HIV) show global inconsistency. Therefore, the present study aimed to investigate the prevalence and genotypic distribution patter...

(This article belongs to the Section Infectious Diseases)
  • Communication
  • Open Access
2 Citations
2,338 Views
8 Pages

HCV-HIV Chronic Coinfection Prevalence in Amazon Region

  • Marcio Nahum Lobo,
  • Susan Denice Flores Irias,
  • Pedro Leão Fontes Neto,
  • Maria Eduarda Sousa Avelino and ,
  • Maria Karoliny da Silva Torres,
  • Marlinda de Carvalho Souza,
  • Ricardo Roberto Souza Fonseca,
  • Pedro Eduardo Bonfim Freitas,
  • Heloisa Marceliano Nunes and
  • Luiz Fernando Almeida Machado
  • + 8 authors+ 3 authors

8 December 2022

Hepatitis C virus (HCV) infection is an important public health problem, especially in areas with a low human development index such as the Amazon region. This study aimed to identify the prevalence and genotypes of HCV among people living with HIV (...

(This article belongs to the Special Issue Chronic HCV Infection: Clinical Advances and Eradication Perspectives - Part II)

of 40